Serofene

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serofene

What is Serofene?

Serofene is an oral medication primarily used in the field of reproductive medicine to assist individuals who experience difficulties with ovulation. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Its primary function is to stimulate the hormonal processes necessary for the development and release of a mature egg from the ovaries.

Mechanism of Action

The medication works by interacting with estrogen receptors in the brain, specifically within the hypothalamus and pituitary gland. By blocking these receptors, Serofene leads the body to perceive that estrogen levels are lower than they actually are. In response, the pituitary gland increases the production of two essential hormones:

  • Follicle-Stimulating Hormone (FSH): This hormone triggers the growth and maturation of ovarian follicles, which contain the eggs.
  • Luteinizing Hormone (LH): An increase in this hormone eventually triggers the release of the egg, a process known as ovulation.

Primary Use

Serofene is most commonly utilized for the treatment of ovulatory dysfunction. This includes conditions such as polycystic ovary syndrome (PCOS), where irregular or absent menstrual cycles prevent natural conception. By inducing ovulation, the medication creates an opportunity for fertilization to occur through natural intercourse or assisted reproductive techniques.

Composition

The active ingredient in Serofene is clomiphene citrate. It is typically produced in tablet form for oral administration. While it is a well-established option for addressing certain types of infertility, its effectiveness depends on the underlying cause of the reproductive challenge and the functional capacity of the ovaries and pituitary gland.

Regulatory References

  1. Clomifene Citrate Overview

What side effects are possible with Serofene?

Possible Side Effects and Safety Information

Serofene (clomiphene citrate) is associated with a range of documented side effects, from common, mild occurrences to rare, serious adverse events requiring immediate attention. Safety information mandates careful patient evaluation before and during each treatment cycle.

Adverse Reaction Category Examples & Frequency
Common (1% to 10%) Ovarian enlargement, vasomotor flushes (hot flashes), headache, nausea, and vomiting.
Less Common Abdominal-pelvic discomfort, breast discomfort, and various visual symptoms.

Serious and Clinically Significant Safety Concerns

  • Ovarian Hyperstimulation Syndrome (OHSS): A potentially serious condition characterized by ovarian enlargement, abdominal discomfort, and fluid accumulation. Although rare with this medication, OHSS can progress rapidly and may be fatal.
  • Visual Disturbances: Blurred vision, scotomata (spots or flashes of light), or other changes may occur. These symptoms can increase with higher total doses or prolonged duration of therapy, and may occasionally be persistent even after stopping the medication.
  • Ovarian Cancer Risk: Long-term use of Serofene (over a total of six cycles) has been associated with an increased risk of borderline or invasive ovarian tumors. Use is generally limited to mitigate this potential risk.
  • Multiple Gestation: The medication increases the probability of conceiving twins, triplets, or higher-order multiples, which carries increased obstetric risks.

Restrictions and Contraindications

Serofene is contraindicated in patients who are pregnant, or have a history of liver dysfunction, unexplained abnormal uterine bleeding, an ovarian cyst (not related to polycystic ovary syndrome), or a pituitary tumor. Because of the risk of visual symptoms, patients are cautioned regarding activities such as driving or operating machinery under conditions of variable lighting.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes officially documented overdose information for Serofene (Clomifene Citrate), strictly based on government regulatory documents.


Overdose Manifestations and Complications

Classification Documented Presentations
Symptom Cluster Visual blurring, scotomata (blind spots), scintillating scotomata (flashing blind spots), nausea, vomiting, vasomotor flushes (hot flushes), and pelvic pain.
Serious Outcome The risk of Ovarian Hyperstimulation Syndrome (OHSS) is noted as a significant complication of excessive stimulation, which may occur in overdose. Severe OHSS, presenting with severe abdominal pain or shortness of breath, is a life-threatening scenario.

Required Emergency Actions

Action Domain Regulatory Statement
Immediate Help Immediate medical attention must be sought for any known or suspected overdose. Contact emergency services immediately if severe symptoms like abdominal pain or difficulty breathing develop.
Management Treatment is symptomatic and supportive. There is no specific antidote known for Clomifene Citrate overdose. Measures to reduce absorption, such as gastric lavage or the administration of activated charcoal, may be considered.
Monitoring Hospital monitoring may be required to manage potential complications.

The regulatory profile strictly mandates urgent intervention upon suspicion of overdose due to the potential for severe, documented complications like OHSS, and notes the supportive nature of the required medical treatment.

Therapeutic Uses of Serofene

What Serofene Treats: Main Uses and Benefits

Serofene (Clomiphene Citrate) is a medication primarily used in situations involving certain distressing symptoms related to fertility challenges due to ovulatory dysfunction. The medicine is specifically indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. The drug is applied across domains where additional symptomatic support is needed, addressing conditions characterized by periods of heightened symptoms.


Managing Symptoms Related to Functional Stability

The medication is applied in clinical settings that involve acute or unstable symptom patterns where additional symptomatic support is needed. It helps address symptom clusters that may become intense or disruptive and is relevant in contexts marked by increased discomfort or tension related to symptoms associated with acute or episodic changes. The medication is used in areas where short-term symptom management is appropriate and symptoms create noticeable functional strain. It is commonly used across conditions presenting with acute episodes and relevant in situations involving recurrent or episodic manifestations.


Supporting Comfort During Symptomatic Periods

This medication assists with maintaining functional stability by addressing symptoms linked to organ-specific functional stress. It supports patients during episodes of heightened discomfort and helps them cope more steadily with symptom fluctuations. The medication provides support that contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Supports Functional Stability

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Serofene

Serofene (clomiphene citrate) is strictly regulated for use only in women of reproductive potential who are experiencing ovulatory dysfunction and actively desiring pregnancy.

Absolute Prohibitions (Contraindications)

The medicine must not be used by individuals with the following conditions or states, as stated in official labeling:

  • Pregnancy Status: The drug is contraindicated and a patient must be tested to exclude pregnancy before and between each treatment course.
  • Liver Health: Individuals with active liver disease or a documented history of liver dysfunction.
  • Endocrine Function: Uncontrolled thyroid or adrenal gland dysfunction.
  • Neurological Conditions: Presence of an organic intracranial lesion, such as a pituitary tumor.
  • Gynecological Issues: Ovarian cysts or enlargement not associated with Polycystic Ovary Syndrome (PCOS), or abnormal uterine bleeding of undetermined origin.

Conditional and Restricted Use

Use is allowed only under specific conditions for certain populations:

  • Uterine Fibroids: Caution is required as use may potentially enlarge existing fibroids.
  • Pelvic Exam: A complete pelvic examination is required before the first course and subsequently before each new course of therapy.
  • Breastfeeding: Use requires caution as the drug may potentially reduce lactation.
  • Duration: Long-term or prolonged cyclic therapy (typically defined as more than six cycles) is generally not recommended.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Serofene (Clomifene Citrate)

Interaction Scope

Category Official Regulatory Documentation Statement
Medicinal product categories with documented interactions Selective Estrogen Receptor Modulators (SERM) are implicated in pharmacodynamic synergism.
Specific interacting medicines (if explicitly listed) Ospemifene (formally contraindicated combination). Benazepril (documented pharmacodynamic interaction).
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic synergism (documented for contraindicated combinations and specific drug interactions).
Timing-based interaction rules (if applicable) None explicitly listed in the official regulatory prescribing information.
Population-specific interaction notes (if applicable) Hepatic Dysfunction / Liver Disease: Compromised clearance is associated with an official risk of increased serum concentration and prolonged half-life of Clomifene Citrate.
Interaction-related restrictions Co-administration with Ospemifene is prohibited due to the risk of pharmacodynamic synergism.

Interaction Classifications (High-Level)

Classification Official Regulatory Documentation Statement
Interaction severity classification (as defined in official documents) Contraindicated Combination (Ospemifene). Clinically Significant Interaction (e.g., pharmacodynamic synergism with specific agents).
Regulatory basis (EMA / FDA / etc.) Based on official labeling from national and international regulatory authorities.
Interaction-context constraints (as defined in official documents) A history of hepatic dysfunction is a documented constraint on safe use related to altered drug exposure.

Resulting Interaction Structure

Official interaction statements:

  • Co-administration of Serofene with Ospemifene is formally contraindicated due to the potential for pharmacodynamic synergism.
  • Interactions involving Benazepril are documented, showing pharmacodynamic synergism that may officially lead to an increased risk of hypotension.
  • Impairment of liver function (Hepatic Dysfunction) is associated with an official increased serum concentration and prolonged half-life of Serofene, a pharmacokinetic alteration due to compromised clearance.
  • No specific interactions with food, alcohol, herbal products, or supplements are explicitly documented in the core regulatory prescribing information.

Connection to the overall interaction profile (2–4 sentences): Official regulatory documents define the interaction structure primarily through two domains: formal restrictions against specific pharmacodynamic synergism (e.g., Ospemifene) and critical warnings concerning population-specific exposure modification (Hepatic Dysfunction). This profile focuses on explicit regulatory constraints and consequences, such as prohibited combinations and the risk of altered drug concentration, rather than broad metabolic or transporter-based interaction mechanisms not formally specified in the label.

Mechanism of Action

Selective Modulation of Central Estrogen Receptors

Serofene (Clomifene Citrate) acts as a Selective Estrogen Receptor Modulator (SERM) by engaging in competitive binding with Estrogen Receptors (ERs), primarily within the hypothalamus. This interaction creates an antiestrogenic effect at the central level, which mechanistically interrupts the body's normal negative feedback inhibition loop.

⏫ Triggering the Gonadotropin Cascade

The perceived lack of estrogen signaling prompts the hypothalamus to respond with a significant increase in Gonadotropin-Releasing Hormone (GnRH). This heightened GnRH activity stimulates the anterior pituitary gland to release a surge of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH), which act as the systemic messengers that regulate the physiological progression of the reproductive cycle.

Promoting Follicle Maturation

The elevated levels of FSH and LH act directly on the ovaries, initiating folliculogenesis—the process of promoting ovarian follicle growth and maturation. This sequence supports the physiological development of ovarian follicles and culminates in the natural pre-ovulatory LH surge, which is the biological event that results in follicular rupture.

Dosage and Administration Information

How to Use Serofene (Clomifene Citrate)

Serofene is administered according to a strict, cyclic schedule based on official prescribing information, and its use is limited to a finite number of treatment courses. The medication is an oral tablet and is taken once daily, strictly as directed by a specialist.

Official Administration Protocol

Instruction Entity Official Guideline
Route of Administration Oral (by mouth).
Dosing Schedule Initial Course: 50 mg once daily for 5 days. Second Course: 100 mg once daily for 5 days, if the desired biological event does not occur after the first course. The maximum daily dose is 100 mg.
Starting Time Dosing typically begins on or about the 5th day of the menstrual cycle. If spontaneous bleeding is absent, therapy may be initiated at any time.
Treatment Interval A new course must not be started until at least 30 days have passed since the previous course, and pregnancy has been excluded.

Procedural Structure and Use Constraints

The full regimen is defined by a sequential protocol designed for intermittent use. Before starting the first course and prior to each subsequent course, a thorough pelvic examination is mandatory. This procedural requirement is tied directly to the proper administration of the medicine. The standard treatment is limited in duration: Serofene is not recommended to be used for more than a total of six cycles. Furthermore, if the patient does not respond by ovulating after three consecutive courses, further therapy is generally considered to be at the limit of its recommended use. The official protocol also notes that patients with Polycystic Ovary Syndrome (PCOS) may require particular consideration for a shorter duration or lower dose if unusual ovarian sensitivity is suspected.

Recent Clinical Evidence

Serofene: Recent Clinical Evidence

The research supporting the use of Serofene has primarily focused on the evaluation of outcomes related to subfertility caused by ovulatory dysfunction. This evidence base consists mainly of Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that synthesize data from numerous studies. Research has examined functional reproductive measures, such as whether ovulation occurred, and key endpoints including the Clinical Pregnancy Rate and the Live Birth Rate.

RCTs represent the controlled study design most commonly used for this medicine. These trials included adult women desiring pregnancy diagnosed with ovulatory dysfunction, with a significant focus on the subgroup presenting with Polycystic Ovary Syndrome (PCOS). Studies observed women over defined time intervals, typically tracking outcomes across a few treatment cycles. The findings describe group patterns observed in these specific populations, but research does not determine whether an individual will respond similarly.

The overall evidence is considered Moderate regarding the consistency of findings for this patient population. However, the research landscape has key limitations: the follow-up durations in primary efficacy trials were often limited to the short-term treatment phase, and long-term effects are not fully established. Furthermore, evidence quality varies across studies, and research comparing Serofene to some alternative pharmacological agents is limited. Data for complex patient groups or those requiring multiple, long treatment cycles remain insufficient to draw broad conclusions. The existing research provides context but not individual predictions.

Key Studies & References Fertility drugs and cancer: a guideline (2024) - American Society for Reproductive Medicine (ASRM)

Frequently Asked Questions (FAQ)

Common questions about Serofene (FAQ)


Q: Does Serofene work for men or only women?

The official regulatory documents state that Serofene is indicated for the treatment of ovulatory dysfunction in women who are actively seeking pregnancy. Regulatory documents describe the use as specific to addressing female subfertility caused by issues with ovulation.

Q: Can Serofene cause mood swings or changes in emotion?

Yes, official post-marketing reports have documented changes in mental or emotional status as an adverse reaction. These changes have been noted in post-marketing reports and included instances of mood alterations and depression.

Q: How quickly does Serofene start to affect the body?

Official regulatory pharmacokinetic information shows that the medication is readily absorbed into the body when taken by mouth. However, the official documentation does not specify the exact time frame for when the main therapeutic effect, such as ovulation, may occur.

Q: Are there generic versions of Serofene available?

The active ingredient in Serofene is Clomiphene Citrate. Clomiphene Citrate is available as a generic medicine recognized by regulatory authorities.

Q: Can Serofene affect vision or eyesight?

Yes, official documents list visual symptoms, such as blurred vision or seeing spots (scotomata), as a possible adverse reaction. The safety information also indicates that these visual disturbances may be prolonged and, in some instances, potentially irreversible.

Q: What is the typical time frame for the effects of Serofene to wear off after the last dose?

Regulatory pharmacokinetic data, which describes how the body processes the drug, shows that traces of the compound can remain in the body for an extended period. Some evidence of the drug or its metabolites has been detected in the body for up to six weeks following a dose.

Q: Why do people sometimes need to use Serofene for multiple cycles?

The official administration protocol is designed for sequential use, meaning a course may be repeated. This is allowed if the desired biological event, such as ovulation, has not occurred following the first treatment course.

Q: What percentage of users report common side effects from Serofene?

Clinical trial data provides the frequency for many adverse reactions. For instance, official documents list vasomotor flushes, or hot flashes, as a reaction reported by approximately 10.4% of patients, while abdominal discomfort or bloating was reported by about 5.5%.

Q: Is it possible to be allergic to Serofene?

Yes, a known hypersensitivity or allergy to Clomiphene Citrate or any of its ingredients is listed as a contraindication for use in the official regulatory documents. This means the medicine must not be used by individuals with such an allergy.

Q: How do regulatory bodies classify the safety of Serofene?

Official regulatory documents classify the use of Serofene during pregnancy as contraindicated. This decision is based on animal studies that showed potential harm to the developing fetus, including increased structural malformations.

Q: Are headaches a common side effect of Serofene?

Yes, based on official clinical trial data, headache is listed as a commonly reported adverse reaction experienced by patients taking this medication.

Q: Is it normal to feel bloated while taking Serofene?

Official regulatory data lists abdominal-pelvic discomfort, distension, or bloating as a commonly reported adverse reaction. This reaction was noted in over 5% of patients during clinical trials.

Q: Do official documents mention any expected feeling of flushing or hot flashes with Serofene?

Yes, the official adverse event tables list vasomotor flushes, which are commonly known as hot flashes. This is noted as a frequently reported reaction, occurring in over 10% of patients in clinical trials.

Q: Is Serofene linked to any changes in breast tenderness?

Breast discomfort or tenderness is described as a commonly reported adverse reaction in official regulatory documentation.

Q: Is Serofene known to cause weight gain?

Official safety warnings list rapid weight gain as a potential sign of the rare, serious condition known as Ovarian Hyperstimulation Syndrome (OHSS). General weight gain is not specifically listed among the most common adverse reactions reported in the regulatory documents.

Q: Does Serofene interact with common pain relievers like ibuprofen?

Official regulatory information does not explicitly list specific interactions with common general pain relievers such as ibuprofen.

Q: Does Serofene have long-term side effects that official documents discuss?

Official regulatory documents advise caution regarding long-term or prolonged cyclic therapy, which is typically defined as use over six cycles. This warning is due to an observed association between extended use and an increased risk of ovarian tumors.

Q: Do studies suggest a link between Serofene and multiple births?

Official warnings indicate that Serofene can increase the probability of having multiple gestations, such as twins. This increase in multiple births carries associated obstetric risk, as noted in the official safety information.

Q: How is Serofene described in official documents regarding use during pregnancy?

Use during pregnancy is formally contraindicated by regulatory documents. Based on animal studies, patients are advised of the potential risks to the fetus, which included increased embryofetal loss and structural malformations.

Q: Can Serofene be used by someone with PCOS?

Yes, official regulatory documents explicitly identify patients with Polycystic Ovary Syndrome (PCOS) as a population for whom Serofene is indicated. It is intended for the treatment of ovulatory dysfunction in this population.

Q: How does Serofene affect the body's natural cycle?

The medication is described as working by binding to estrogen receptors, which temporarily interrupts the body's normal hormone feedback process. This interaction results in an increased release of hormones that stimulate ovarian follicle growth and development.

Q: Can drinking coffee or caffeine affect Serofene?

Regulatory information for Serofene does not explicitly list specific interactions with caffeine.

Q: Does Serofene work the same way for all patients?

The official guidance recognizes that not all patients will respond to the initial course of therapy in the same way. The treatment protocol describes an approach that allows for an adjusted course, such as a subsequent course with a different dose, if the patient does not ovulate initially.

How should Serofene be stored and disposed of?

How to Store and Dispose of Serofene

Serofene (clomiphene citrate) must be stored according to official regulatory requirements to maintain its stability and effectiveness.

Storage Conditions

Store the tablets at controlled room temperature, typically between 59 F and 86 F (15 C and 30 C). The product must be kept in its original container with the lid tightly closed and should be protected from heat, moisture, and direct light. Do not freeze the medication. For child safety, the medicine must be stored out of the reach and sight of children.

Disposal Instructions

Unused or expired Serofene should not be flushed down a sink or toilet. The preferred method of disposal is through a drug take-back program. If a take-back program is unavailable, the tablets should be mixed with an undesirable substance (such as dirt or used coffee grounds) and placed in a sealed container before being thrown in the household trash. Disposal must comply with all local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serofene found in:

A-Z Index: